Coinfections with Schistosoma haematobium, Necator americanus, and Entamoeba histolytica/Entamoeba dispar in children: chemokine and cytokine responses and changes after antiparasite treatment.
The effect of polyparasite infections on cytokine and chemokine responses as well as the effect of antiparasite treatment was studied in children without parasite infection (the G0 group), in children singly infected with Schistosoma haematobium (the G1 group), and in children multiply infected with S. haematobium/Schistosoma mansoni, Entamoeba histolytica/Entamoeba dispar, and Necator americanus (the G3+ group). Linear regression analysis disclosed a significant risk for coinfection with hookworm and Schistosoma species. Polyparasite infections detected in 23% of children before treatment were present in 5% at 15 months after treatment. Chemokine responses to S. mansoni adult worm antigen (SmAg) diminished after treatment for macrophage inflammatory chemokine (MIP)-1alpha/chemokine (C-C motif) ligand (CCL)-3 (among G3+ children, by a factor of 200 [95% confidence interval {CI}, 33-1111]) and for MIP-1beta/CCL-4 (among G3+ children, by a factor of 26 [95% CI, 6-117]) but were enhanced for thymus- and activation-regulated chemokine/CCL-17 (among G3+ children, by a factor of 10 [95% CI, 3-32]) (P < .001 for all). In response to E. histolytica antigen, interleukin (IL)-13 levels increased after treatment among G1 children by a factor of 138 (95% CI, 12-1569) and among G3+ children by a factor of 21 (95% CI, 7-64) (P < .001 for both). Cellular production of interferon (IFN)-gamma in response to SmAg decreased 4 weeks after treatment among G3+ children, whereas T helper cell type 2 (Th2) IL-13 production was enhanced among G1 and G3+ children. In summary, polyparasite infections with S. haematobium/S. mansoni, E. histolytica/E. dispar, and N. americanus generated prominent proinflammatory cytokine and chemokine responses, and, after antihelminth treatment, the inflammatory chemokine response lessened as the Th2 responsiveness in coinfected children increased.
Hamm
David M
DM
Institute for Tropical Medicine, University Clinics of Tübingen,Tübingen, Germany.
Agossou
Abram
A
Gantin
Richard G
RG
Kocherscheidt
Lars
L
Banla
Meba
M
Dietz
Klaus
K
Soboslay
Peter T
PT
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D018925:Chemokines / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D016000:Cluster Analysis; D016207:Cytokines / Q000378:metabolism; D004748:Entamoeba histolytica; D004749:Entamoebiasis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006373:Helminthiasis; D006801:Humans; D017221:Necator americanus; D009332:Necatoriasis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D012548:Schistosoma haematobium; D012553:Schistosomiasis haematobia / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D014037:Togo
D000871:Anthelmintics; D000981:Antiprotozoal Agents; D018925:Chemokines; D016207:Cytokines